KEYMED BIO-B

2162
69.0001.22% ( -0.850 )
Delay Closed: Nov 16, 16:08:11

Valuation

Current ValuationThe current P/E ratio is 23.14, above the reasonable range, cheaper than 7.29% of the time in the past 3 years, and the industry ranks 16/78, the industry Median -4.86.

23.14xP/E
Stock priceHK$69.00Earnings per shareHK$2.98

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0152304456608

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
02696HKHENLIUS
24.48x25.47%HK$24.45B
02162HKKEYMED BIO-B
23.14x248.55%HK$20.61B
02157HKLEPU BIO
16.88x127.52%HK$4.80B
06826HKHAOHAI BIOTEC
28.37x128.83%HK$3.61B
02181HKMABPHARM-B
20.51x--HK$2.02B
06915HKJIANGXI BIO
20.91x--HK$1.74B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.